KINIKSA PHARMACEUTICALS INTL

Ticker: KNSA CUSIP: G52694109 Class: Common Stock

CITADEL ADVISORS LLC's Holding History (CIK: 0001423053)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 742,118 Value ($000) $30,612 Avg Close $40.11 Range $35.20 - $44.42

Q3 2025

Shares 314,556 Value ($000) $12,214 Avg Close $32.49 Range $26.27 - $39.00

Q2 2025

Shares 267,393 Value ($000) $7,399 Avg Close $25.46 Range $18.25 - $30.69

Q1 2025

Shares 60,647 Value ($000) $1,347 Avg Close $20.58 Range $17.82 - $24.31

Q4 2024

Shares 304,576 Value ($000) $6,025 Avg Close $22.82 Range $19.47 - $28.15

Q3 2024

Shares 198,413 Value ($000) $4,958 Avg Close $24.36 Range $17.38 - $27.92

Q2 2024

Shares 54,820 Value ($000) $1,023 Avg Close $18.73 Range $16.56 - $20.52

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	742,118	$30,612	$40.11	$35.20 - $44.42
Q3 2025	314,556	$12,214	$32.49	$26.27 - $39.00
Q2 2025	267,393	$7,399	$25.46	$18.25 - $30.69
Q1 2025	60,647	$1,347	$20.58	$17.82 - $24.31
Q4 2024	304,576	$6,025	$22.82	$19.47 - $28.15
Q3 2024	198,413	$4,958	$24.36	$17.38 - $27.92
Q2 2024	54,820	$1,023	$18.73	$16.56 - $20.52